NDC 70332-106

Tabradol

Cyclobenzaprine Hydrochloride

Tabradol is a Oral Kit in the Human Prescription Drug category. It is labeled and distributed by California Pharmaceuticals, Llc. The primary component is .

Product ID70332-106_273003a5-23aa-21e4-e054-00144ff88e88
NDC70332-106
Product TypeHuman Prescription Drug
Proprietary NameTabradol
Generic NameCyclobenzaprine Hydrochloride
Dosage FormKit
Route of AdministrationORAL
Marketing Start Date2016-01-01
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameCalifornia Pharmaceuticals, LLC
Active Ingredient Strength0
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 70332-106-01

1 KIT in 1 KIT (70332-106-01) * .5 g in 1 BOTTLE, GLASS * 125 mL in 1 BOTTLE, PLASTIC * 125 mL in 1 BOTTLE, PLASTIC
Marketing Start Date2016-01-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70332-106-01 [70332010601]

Tabradol KIT
Marketing Categoryunapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2016-01-01
Inactivation Date2020-01-31

Drug Details

OpenFDA Data

SPL SET ID:273003a5-23a9-21e4-e054-00144ff88e88
Manufacturer

NDC Crossover Matching brand name "Tabradol" or generic name "Cyclobenzaprine Hydrochloride"

NDCBrand NameGeneric Name
70332-106TabradolTabradol
43093-101TabradolTabradol
0093-1920Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0093-1921Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0093-3420Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0093-3421Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0093-3422Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0115-1436Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0115-1437Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0179-0057cyclobenzaprine hydrochloridecyclobenzaprine hydrochloride
0179-0189cyclobenzaprine hydrochloridecyclobenzaprine hydrochloride
0378-0751Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
0378-0761Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
0378-0771Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
0440-1350Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0440-7350Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0591-3256Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0591-3330Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0591-5658Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0615-3520Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
0615-7528Cyclobenzaprine Hydrochloridecyclobenzaprine hydrochloride
0615-8182Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride
0904-7809Cyclobenzaprine HydrochlorideCyclobenzaprine Hydrochloride

Trademark Results [Tabradol]

Mark Image

Registration | Serial
Company
Trademark
Application Date
TABRADOL
TABRADOL
85002366 3980334 Dead/Cancelled
Fusion Pharmaceuticals
2010-03-30
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.